Medical Oncology· Topic 12.5 Cancers of the skin, bone, and soft tissue· 12.5.7

Basal cell carcinoma

Basal cell carcinoma is the most common skin cancer, arising from the basal layer of the epidermis after ultraviolet-driven mutation of the PTCH tumor-suppressor gene, and it rarely metastasizes but can cause significant local tissue destruction if untreated. Diagnosis is confirmed by shave or punch biopsy, and treatment is chosen by risk: standard excision or Mohs micrographic surgery for higher-risk tumors, with curettage and electrodesiccation or topical imiquimod or fluorouracil reserved for low-risk superficial or nodular disease.

12 min read5 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: basal cell carcinoma (BCC) is a malignant neoplasm arising from the basal layer of the epidermis.

  • Epidemiology

    Population burden: nonmelanoma skin cancers, principally basal cell and squamous cell carcinoma, are the most common malignancies diagnosed in the United States.

  • Risk factors

    Ultraviolet light exposure: the major risk factor, with basal cell carcinoma more strongly correlated with sun exposure at a younger age and intense, intermittent exposure than squamous cell carcinoma.

  • Pathophysiology

    Cell of origin: BCC arises from the basal layer of the epidermis, the germinative layer responsible for keratinocyte renewal.

  • Clinical features

    Nodular BCC (most common): a pearly or translucent nodule or papule with arborizing telangiectasias, often with a central depression or ulceration and a rolled, waxy border classically called a…

  • Differential diagnosis

    Actinic keratosis: rough, scaly, and often tender on palpation, without the pearly translucency or rolled border seen in superficial or nodular BCC.

  • Diagnosis

    First, biopsy establishes the diagnosis: a shave or punch biopsy confirms BCC and shows the classic pattern of basaloid cell nests with peripheral palisading and retraction artifact (clefting) between tumor and dermis.

  • Management

    First, risk-stratify the tumor by subtype, size, location, and whether it is primary or recurrent, since this determines which of the following options is appropriate.

  • Complications

    Local tissue destruction: untreated basal cell carcinomas can enlarge and cause significant local tissue damage if left in place for a prolonged period.

  • Prognosis

    Generally excellent: BCC usually grows slowly and is locally invasive rather than aggressive, and it is rarely fatal.

  • Prevention

    Routine sunscreen use: apply a sunscreen with a sun protection factor greater than 35 as a routine measure to reduce cumulative ultraviolet exposure.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.